Professor Steve Petrou
Deputy director of the Florey Institute, Head of the division of epilepsy and lead of Therapeutic Innovation Australia.
Professor Steven Petrou is Deputy Director of the Florey Institute for Neuroscience and Mental Health and Head of the Florey’s Division of Epilepsy. He heads the Laboratory of Ion Channels and Human Disease, a multidisciplinary team of researchers with a focus on revealing fundamental mechanisms of disease genesis in the central nervous system. Current major areas of investigation centre on the development and characterisation of genetically engineered mice models for the study of human familial epilepsy. He works closely with industry and has several patents for his discoveries. In addition to his many roles within the Florey Institutes and the University of Melbourne, he serves on the editorial board of the Journal Neurobiology of Disease and the Investigators Workshop Committee for the American Epilepsy Society.
Links to some of Professor Petrou’s research papers can be found here (https://www.florey.edu.au/user/5480).
Watch the talk
Therapeutic approaches in neurogenetic disease
Knowledge of the genetic underpinnings of a disease provides opportunities to develop therapies that precisely target disease mechanisms. The talk will introduce three major modalities that can be used to deliver on the promise of “precision medicine”. In particular the promise of RNA based therapies that can precisely address many of the common genetic disease mechanisms.
Watch the talk
Panel discussion with all the speakers chaired by Sara James
Professor Annapurna Poduri, Professor Ingrid Scheffer, Dr Snezana Maljevic, Assoc Professor Gavin Rumbaugh, Professor Steve Petrou, Professor Glenn King, Sara James (Chair)
To round out the Genetic Epilepsy Family Conference 2018, all the invited speakers formed a panel to take questions and discuss points raised across the day.